Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Pharmasset Inc | d10q.htm |
| EX-31.2 - RULE 13A-14(A)/15D-14(A) CERTIFICATION - Pharmasset Inc | dex312.htm |
| EX-31.1 - RULE 13A-14(A)/15D-14(A) CERTIFICATION - Pharmasset Inc | dex311.htm |
| EX-32.1 - SECTION 1350 CERTIFICATION - Pharmasset Inc | dex321.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report on Form 10-Q of Pharmasset, Inc. (the “Company”) for the period ended June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Kurt Leutzinger, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 9, 2010
| /S/ KURT LEUTZINGER |
| Kurt Leutzinger Chief Financial Officer |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.